Intrinsic Value of S&P & Nasdaq Contact Us

Aspira Women's Health Inc. AWH NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
46/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.30
+3924.4%

Aspira Women's Health Inc. (AWH) is a Medical - Diagnostics & Research company in the Healthcare sector, currently trading at $0.08. It has a SharesGrow Score of 46/100, indicating a mixed investment profile with 3 out of 7 criteria passed.

Analyst consensus target is AWH = $3 (+3924.4% upside).

Financials: revenue is $9M, +4.2%/yr average growth. Net income is $13M (loss), growing at +15.5%/yr. Net profit margin is -138.7% (negative). Gross margin is 64.2% (+11.4 pp trend).

Balance sheet: total debt is $2M with negative equity of -$7M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 1.17 (adequate). Debt-to-assets is 45.6%. Total assets: $5M.

Analyst outlook: 3 / 5 analysts rate AWH as buy (60%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 63/100 (Pass), Past 0/100 (Fail), Health 25/100 (Fail), Moat 50/100 (Partial), Future 73/100 (Pass), Income 10/100 (Fail).

$3.30
▲ 3924.39% Upside
Average Price Target
The 12-month price target for Aspira Women's Health Inc. is $3.30.

AWH SharesGrow Score Overview

54/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 100/100
Valuation — P/E, PEG, Forward PEG
GROWTH 63/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 25/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 50/100
Gross margin is + market cap
FUTURE 73/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Stock Chart & Stats

Market Data
52-Week Range0.08-3.63
Volume443.52K
Avg Volume (30D)4.52M
Market Cap$2.46M
Beta (1Y)2.01
Share Statistics
EPS (TTM)-0.37
Shares Outstanding$34.1M
IPO Date2000-10-02
Employees66
CEONicolette Possemato
Financial Highlights & Ratios
Revenue (TTM)$9.22M
Gross Profit$5.92M
EBITDA$-7.91M
Net Income$-12.78M
Operating Income$-7.91M
Total Cash$1.76M
Total Debt$2.49M
Net Debt$732K
Total Assets$5.46M
Price / Earnings (P/E)-0.2
Price / Sales (P/S)0.27
Analyst Forecast
1Y Price Target$3.30
Target High$3.30
Target Low$3.30
Upside+3,924.4%
Rating ConsensusBuy
Analysts Covering5
Buy 60% Hold 40% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS04537Y2081

Price Chart

AWH
Aspira Women's Health Inc.  ·  NASDAQ Capital Marke
Healthcare • Medical - Diagnostics & Research
0.08 52WK RANGE 3.63
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message